Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients
This is a retrospective study aiming to investigate the effect of the number of high dose cytarabine-based chemotherapy (HiDAC) courses in patients with acute myeloid leukemia before allogenic stem cell transplantation (ASCT).
Source: Transfusion and Apheresis Science - Category: Hematology Authors: Rafiye Ciftciler, Haluk Demiroglu, Yahya Buyuka şık, Mufide Okay, Salih Aksu, Nilgun Sayınalp, Umit Yavuz Malkan, Ibrahim Celalettin Haznedaroglu, Osman Ozcebe, Hakan Goker Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Hematology | Leukemia | Science | Stem Cell Therapy | Stem Cells | Study | Transplants